Skip to main content
WAT
NYSE Life Sciences

Waters Beats Q3 Estimates, Lifts Full-Year Revenue and EPS Outlook

Tom Rudovsky · Reported by Reuters
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$457
Mkt Cap
$44.165B
52W Low
$282.77
52W High
$482.28
52W Position info
62% above low
Off High info
5.2% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

WAT sits 62% above its 52-week low of $282.77 on elevated volume (2.4× avg).

Summary

Waters beat on both lines for Q3: sales of $1.77B topped the $1.75B consensus and adjusted EPS of $4.10 came in above the $4.00 estimate, with adjusted EPS up 21% year over year. Management raised full-year 2026 revenue guidance to $6.479B-$6.497B and lifted adjusted EPS to $14.60-$14.70, and guided Q4 to $1.801B-$1.819B in revenue and $4.58-$4.68 in adjusted EPS. The beat was broad: double-digit instrument and chemistry consumables growth in Analytical Sciences, high single-digit reagent growth in Biosciences (a 400bps acceleration), and LC-MS demand tied to replacement cycles plus GLP-1, PFAS and India generics. This follows the Q2 10-Q showing revenue more than doubled to $1.645B after the BDS acquisition but a $136M net loss on amortization and restructuring, so the raised outlook is the first clear sign the combined business is converting growth into earnings. The stock closed at $449.53 on November 2 and trades at 28x next-12-month earnings versus 24x three months ago, so the bar was already higher.

At the time of this announcement, WAT was trading at $457.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $44.2B. The 52-week trading range was $282.77 to $482.28. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

WAT - Latest Insights

WAT
Nov 10, 2026, 4:31 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $475.52
Real-time Price: $465.87 info
Change: -$9.65 (-2%) info
Market Cap: $45.811B info
WAT
Nov 03, 2026, 8:11 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $456.00
Real-time Price: $465.87 info
Change: +$9.87 (+2%) info
Market Cap: $45.811B info
WAT
Aug 11, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $414.59
Real-time Price: $465.87 info
Change: +$51.28 (+12%) info
Market Cap: $45.811B info
WAT
Aug 04, 2026, 7:04 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $373.00
Real-time Price: $465.87 info
Change: +$92.87 (+25%) info
Market Cap: $45.811B info
WAT
Aug 04, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $364.69
Real-time Price: $465.87 info
Change: +$101.18 (+28%) info
Market Cap: $45.811B info